Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Intern Med ; 22(6): 603-6, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22075288

RESUMO

INTRODUCTION: The relation of AAT phenotype and COPD still raises lots of controversy. In this study we aimed to investigate relation lung function characteristics, AAT serum level and COPD in smoking and non smoking population. PATIENTS AND METHODS: This was a prospective non-randomized study in which we evaluated 45 patients with severe (stage IV) COPD. In all patients we determined AAT phenotype, serum AAT levels and lung function tests. We correlated findings in relation to the smoking status. RESULTS: All patients were MM type homozygotes. Serum AAT concentrations were within the reference values, amounting to 1.66g/l in smokers and 1.80g/l in nonsmokers. There was no significant correlation between serum AAT concentrations and lung function parameters. We have observed the higher mean values of ITGV, RV, TLC and RV/TLC in smokers and a statistically significant difference only in ITGV. CONCLUSION: All of the investigated patients with severe COPD were MM type homozygotes with normal plasma level of AAT. There was no significant correlation between the phenotype and severity of COPD. We did not find significant relation of plasma AAT level and lung function impairment.


Assuntos
Doença Pulmonar Obstrutiva Crônica/genética , Fumar/genética , Deficiência de alfa 1-Antitripsina/genética , alfa 1-Antitripsina/genética , Idoso , Enfisema/sangue , Enfisema/epidemiologia , Enfisema/genética , Estudos de Associação Genética , Predisposição Genética para Doença/epidemiologia , Predisposição Genética para Doença/genética , Genótipo , Homozigoto , Humanos , Pulmão/fisiologia , Pessoa de Meia-Idade , Fenótipo , Estudos Prospectivos , Doença Pulmonar Obstrutiva Crônica/sangue , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Testes de Função Respiratória , Fatores de Risco , Fumar/sangue , Fumar/epidemiologia , alfa 1-Antitripsina/sangue , Deficiência de alfa 1-Antitripsina/sangue , Deficiência de alfa 1-Antitripsina/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...